Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Macrogenics (MGNX) Inventory Average (2021 - 2025)

Macrogenics (MGNX) has disclosed Inventory Average for 5 consecutive years, with $8.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Inventory Average changed N/A to $8.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $8.3 million, a N/A change, with the full-year FY2023 number at $1.3 million, down 54.24% from a year prior.
  • Inventory Average was $8.3 million for Q4 2025 at Macrogenics, down from $9.0 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $9.4 million in Q2 2025 to a low of $1.1 million in Q4 2023.
  • A 5-year average of $3.8 million and a median of $2.2 million in 2024 define the central range for Inventory Average.
  • Peak YoY movement for Inventory Average: plummeted 69.68% in 2022, then surged 691.37% in 2025.
  • Macrogenics' Inventory Average stood at $4.2 million in 2021, then tumbled by 69.68% to $1.3 million in 2022, then dropped by 9.85% to $1.1 million in 2023, then soared by 90.6% to $2.2 million in 2024, then skyrocketed by 282.2% to $8.3 million in 2025.
  • Per Business Quant, the three most recent readings for MGNX's Inventory Average are $8.3 million (Q4 2025), $9.0 million (Q3 2025), and $9.4 million (Q2 2025).